Department of Medicine 5 – Haematology and Oncology

Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix (2018) Jesinghaus M, Strehl J, Boxberg M, Bruehl F, Wenzel A, Konukiewitz B, Schlitter AM, et al. Journal article Label-Free High-Throughput Leukemia Detection by Holographic Microscopy (2018) Ugele M, Weniger M, Stanzel M, Bassler M, Krause S, Friedrich O, Hayden O, Richter L Journal article Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s (2018) Binder MT, Becker E, Wiendl M, Schleier L, Fuchs F, Leppkes M, Atreya R, et al. Journal article IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn's disease patients (2018) Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, et al. Conference contribution Hobit- and Blimp1-driven tissue resident memory T cells critically control chronic intestinal inflammation (2018) Zundler S, Becker E, Spocinska M, Parga-Vidal L, Stark R, Atreya R, Rath T, et al. Conference contribution Immune-Epithelial Crosstalk in Inflammatory Bowel Diseases and Mucosal Wound Healing (2018) Leppkes M, Siegmund B, Becker C Journal article, Editorial Detection by flow cytometry of anti-neutrophil cytoplasmic antibodies in a novel approach based on neutrophil extracellular traps (2018) Roitsch S, Goesswein S, Neurath M, Leppkes M Journal article The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitis (2018) Schmitt H, Billmeier U, Ulmschneider J, Admyre C, Knittel T, Zargari A, Neurath M, Atreya R Conference contribution Whole-Body Electromyostimulation Combined With Individualized Nutritional Support Improves Body Composition in Patients With Hematological Malignancies - A Pilot Study (2018) Schink K, Relijic D, Herrmann HJ, Meyer J, Mackensen A, Neurath M, Zopf Y Journal article The tyrosine kinase inhibitor dasatinib reduces the growth of intracellular Mycobacterium tuberculosis despite impairing T-cell function (2018) Wehrstedt S, Kubis J, Zimmermann A, Bruns H, Mayer D, Grieshober M, Stenger S Journal article